Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
BeyondSpring Inc.
organization2 mentionslast seen Oct 6, 2026
Clinical-stage biopharmaceutical company developing therapies for cancer treatment.
Relationships 10
- BeyondSpring Inc.ownsDalian Wanchunbulin Pharmaceuticals Ltd.99% confidence2 sources
- BeyondSpring Inc.employsMin Qiu99% confidence2 sources
- BeyondSpring Inc.developsPlinabulin99% confidence2 sources
- Biolin Investment LimitedacquiresBeyondSpring Inc.95% confidence1 source
- BeyondSpring Inc.developsDUBLIN-493% confidence1 source
- BeyondSpring Inc.invests inSEED Therapeutics90% confidence1 source
- BeyondSpring Inc.partners withBiolin Investment Limited88% confidence1 source
- Biolin Investment LimitedacquiresBeyondSpring Inc.85% confidence1 source
- Biolin Investment LimitedsuppliesBeyondSpring Inc.82% confidence1 source
- BeyondSpring Inc.authoredDUBLIN-3 Trial75% confidence1 source
Relationship
BeyondSpring Inc.developsPlinabulin
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 6, 2026BeyondSpring Inc. 8-K: Item 2.01: Completion of Acquisition or Disposition of Assets; Item 9.01: Financial Statements and Exhibits
DUBLIN-4, a global Phase 3 trial of Plinabulin in combination with docetaxel
- filingSEC EDGARSep 29, 2026BeyondSpring Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
lead asset, Plinabulin, has been studied in more than 700 cancer patients and is in late-stage development